Globes -- Merck KGaA of Germany, which deals in chemicals and development of pharmaceuticals, and is traded in Frankfurt and on Nasdaq, is about to set up a biomed incubator in Israel, at its Israeli development center InterLab. Merck’s biotech division, Merck-Serono, will invest €10 million in the venture over seven years.
